Developing vaccines for infectious diseases including SARS-CoV-2
Official title: Task V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
Funded at Advanced Bioscience Laboratories, INC. · NIH-10168825 · Data updated 2026-11-12
This study is all about creating new vaccines to help protect people from infectious diseases like COVID-19, and it's aimed at making sure these vaccines are safe and effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $31,202 |
| NIH project number | 272201800009I-0-759302000001-1 |
| Project ID | NIH-10168825 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases, particularly those vulnerable to SARS-CoV-2 and other emerging pathogens.
✕Less likely to help
Patients who are not at risk for infectious diseases or those who have already been vaccinated against SARS-CoV-2 may not receive benefit from this research.
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics to combat infectious diseases, including SARS-CoV-2. It involves planning and optimizing vaccine products, ensuring compliance with regulatory standards, and conducting clinical studies. Patients may benefit from new vaccines that are designed to protect against emerging infectious threats and bioterrorism. The research includes comprehensive support for vaccine formulation and delivery systems.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from serious infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.